Status:
ENROLLING_BY_INVITATION
DESI - Düsseldorfer ESD Study
Lead Sponsor:
Torsten Beyna
Conditions:
Oesophageal Tumour
Gastric Tumours
Eligibility:
All Genders
18+ years
Brief Summary
Safety and effectiveness of endoscopic submucosal dissection
Detailed Description
Background and study objective The standard of care for premalignant and malignant mucosal lesions in the gastrointestinal track with limited submucosal invasion is an endoscopic resection. A curative...
Eligibility Criteria
Inclusion
- signed consent form
- Indication for an ESD in the oesophagus, stomach, duodenum, colon or rectum
- Age \>18 years
Exclusion
- Age \< 18 years
Key Trial Info
Start Date :
September 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2035
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06993402
Start Date
September 10 2024
End Date
September 1 2035
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evangelisches Krankenhaus Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany, 40217